Drawing for CATALENT

USPTO serial 77195432

CATALENT

Reviewed by CopyMark Law Group

Reg. 3496710Status 710
Filing date
Status date
Registration date
Sep 2, 2008
Examiner
KON, ELISSA GARBER
Law office
TMEG LAW OFFICE 106

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CATALENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Vanessa A. Ignacio, Esq.

Vanessa A. Ignacio, Esq. Lowenstein Sandler LLP65 LIVINGSTON AVEROSELAND, NJ 07068-1791UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Advertising; business management; business administration; office functions; business consulting services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and production systems and distribution solutions; business management services, namely, managing logistics, reverse logistics, supply chain services, supply chain visibility and synchronization, supply and demand forecasting and product distribution processes for others; business consulting services in the field of commercialization of pharmaceutical products; distributorship services in the field of pharmaceuticals, biopharmaceuticals, radio pharmaceuticals, health care products and medical products; invoicing services; order fulfillment services; customer service in the field of pharmaceutical product distribution and logistics; electronic customer ordering services for pharmaceuticals pharmaceutical products, medical products and equipment, laboratory supplies and equipment; computerized pharmaceutical record-keeping and pharmaceutical inventory control services; inventory management in the field of pharmaceuticals and pharmaceutical products; computerized tracking and tracing of packages in transit; operation of a telephone call center for others to assist in locating and delivering complex pharmaceuticals and radio pharmaceuticals; packaging of clinical, pharmaceutical and health care products to the order and specification of othersSECTION 8 - CANCELLEDJun 21, 2007
039Warehousing services, namely, storage, distribution, pick-up, packing, and shipping of pharmaceuticals, biopharmaceuticals, radio pharmaceuticals, pharmaceutical products, health care products and medical products; supply chain, logistics and reverse logistics services, namely, storage, transportation and delivery of pharmaceuticals and pharmaceutical products for others by air, rail, ship or truckSECTION 8 - CANCELLEDJun 21, 2007
040Treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals, biopharmaceuticals, nutraceuticals and vitamins; manufacture of pharmaceuticals, biopharmaceuticals, nutraceuticals and vitamins to the order and/or specification of othersSECTION 8 - CANCELLEDJun 21, 2007
042Scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; development of pharmaceuticals, biopharmaceuticals, radio pharmaceuticals, pharmaceutical preparations, vitamins, medicines, pharmaceutical packaging and drug delivery technologies; research and development of new products for others; product development consultation; product research services, namely, providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical consulting and research services for the pharmaceutical industry; consultation in the field of pharmaceutical drug delivery and dosage technologies; custom design and development of chemical reagents and biochemical assaysSECTION 8 - CANCELLEDJun 21, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 5, 2019CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Sep 2, 2017REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jul 26, 2014NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 25, 2014C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 25, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 10, 2014E815TEAS SECTION 8 & 15 RECEIVED—
Sep 2, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 28, 2008REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Jul 25, 2008CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 25, 2008SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 25, 2008AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 15, 2008IUAFUSE AMENDMENT FILED—
Jul 15, 2008EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 10, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 18, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2008NPUBNOTICE OF PUBLICATION—
Feb 11, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 11, 2008ALIEASSIGNED TO LIE—
Jan 9, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 9, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Jan 9, 2008GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 9, 2008GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 9, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 29, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2007DOCKASSIGNED TO EXAMINER—
Jun 7, 2007MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Jun 6, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance